Holstein bull calves ( n = 96) were purchased at approximately 7 d of age and were assigned to receive 400, 450, 500, and 550 g/d of milk replacer solids during wk 1 to 4, respectively. Treatments were nonmedicated milk replacer plus dried whey, medicated milk replacer (138 mg/kg of oxytetracycline and 276 mg/kg of neomycin) plus dried whey, or nonmedicated milk replacer plus whey processed with bgalactosidase to contain 15% galactosyl-lactose. Processed whey was added to provide 1% of dry matter as galactosyl-lactose; an equivalent amount of dried whey was added to the other treatments to provide 6.3% of dry matter daily. Intake of milk replacer and fecal scores were measured daily. No calf starter or hay was fed. Body weights were measured weekly from arrival to 26 d. Serum immunoglobulin G, measured 1 d after arrival, averaged 18.3 g/L. Intake of milk replacer plus additive during the 26-d study was 445 g/d and did not vary with treatment. Body weight and body weight gain were increased by 52 and 72 g/d in response to antibiotics and galactosyl-lactose, respectively. Severity of scours and number of days scouring tended to be reduced when calves were fed milk replacer containing galactosyl-lactose or antibiotics. ( Key words: calves, milk replacer, antibiotics, oligosaccharide)
INTRODUCTION
Prior to weaning, replacement dairy calves are susceptible to many pathogens that cause disease. Antibiotics, which are extensively used in milk replacers [MR; (7) ], have been shown to improve performance and reduce scours in dairy calves (14, 24) . More recently, oligosaccharides have been proposed as a means to manipulate the bacterial flora of the intestinal tract of animals, potentially reducing the incidence of disease. These carbohydrates may reduce the adhesion of certain bacterial species to the intestinal epithelium, most notably Escherichia coli (K99+) and Salmonella sp. (11, 16, 18, 19) . Furthermore, oligosaccharides may also increase the growth of beneficial intestinal bacteria, including lactobacilli and bifidobacteria (4, 9, 11) . Oligosaccharides containing mannose (16, 17, 20) and fructose (9, 25) have been used in the diets of calves and pigs to improve intestinal health and to reduce the incidence of disease. Conversely, Mathew et al. ( 1 2 ) reported no effect of oligosaccharides on nutrient digestibility or ileal concentrations of VFA and lactate in pigs that were weaned early. Intake was increased when 0.5% of the diet contained oligosaccharide.
Galactosyl-lactose ( GL) is a trisaccharide (galactose plus lactose) that is produced by enzymatic treatment of whey using b-galactosidase derived from Aspergillus oryzae ( 5 ) . The objectives of this study were to determine the effect of GL or antibiotic addition to MR on the growth and health of dairy calves.
MATERIALS AND METHODS
Holstein bull calves ( n = 96), approximately 7 d of age, were purchased in two blocks of 48 from sale barns and dairy farms in Tennessee and transported to the experimental facility. Upon arrival, each calf was unloaded, weighed, and placed in an individual fiberglass hutch bedded with straw. Calves were assigned randomly to treatment upon arrival. Approximately 12 h after arrival, a blood sample was collected from the jugular vein of each calf and allowed to clot. Serum was separated by centrifugation (3000 × g for 15 min at 5°C ) and stored (-20°C ) until analysis in duplicate for IgG concentration by radial immunodiffusion (VMRD, Inc., Pullman, WA).
Calves were weighed upon arrival and at 7, 14, 21, and 26 d to calculate BW gain and efficiency of feed 1 Adjusted for initial BW, except initial BW. 2 Treatments: control MR = commercial nonmedicated MR plus 1% whey, MRAB = commercial medicated MR plus 1% whey, and MRGL = commercial nonmedicated MR plus 1% GL.
3 Contrasts: AB = control MR versus MRAB; GL = control MR versus MRGL. 4 Mean fecal score: 1 = normal fecal consistency to 4 = severe scours. 5 P > 0.10. 6 Additives were dried whey (control MR and MRAB) or GL (MRGL) added at 6.3% of DM. antibiotics was recorded for each calf. Electrolytes were fed at an additional feeding (approximately 1200 h ) when calves were visibly dehydrated or when calves had a fecal score >2. When calves were fed electrolytes, milk replacer continued to be fed. Antibiotics were administered for 3 d when the fecal score was >2 or when rectal temperature was ≥39°C. Analgesics were administered when the rectal temperature was ≥39°C.
Remaining MR at each feeding was weighed back and reported daily. Water was available at all times. No calf starter or hay was fed. Samples of MR, whey, and GL were taken weekly, composited, and analyzed for DM, CP, fat, Ca, and P ( 2 ) .
Data were analyzed as a randomized complete block experimental design ( 6 ) using SAS (21) . However, neither blocking effect (shipment of calves) nor the interaction of block and treatment was significant; therefore, data were reanalyzed as a completely randomized experimental design by ANOVA. Calf BW at arrival was included in each model as a covariant. Significance was declared at P < 0.05 unless otherwise noted.
RESULTS AND DISCUSSION
Calves that died within 7 d of arrival at the experimental facility because of failure of passive transfer of immunity, exposure to pathogens during transport, or both, were replaced. Two calves fed MRGL died at 18 and 24 d, respectively, and were not replaced.
The chemical composition of MR (Table 1 ) consistently met or exceeded label guarantees (22% CP and 20% fat, air-dry basis) and met or exceeded NRC ( 1 5 ) recommendations for CP and fat. Composition of the GL product, according to the manufacturer, was 38% lactose, 15.0% GL, 10.6% CP, 3.5% fat, and 11.9% ash (air-dry basis).
Mean serum IgG at 24 h after arrival was 18.3 g/L (SE = 1.3) and ranged from 2.0 to 52.2 g/L ( Table 2) . Failure of passive transfer, defined as ≤10 g/L of serum IgG concentration, was measured in 33% of the calves purchased.
Intake of MR was similar among treatments (Table 2); MR was refused only when calves exhibited signs of disease. Addition of whey or GL did not affect consumption of MR; however, addition of processed whey containing GL required extensive mixing to solubilize the material. Occasionally, clumps of powder were observed in nipple bottles of calves fed MRGL, indicating incomplete mixing. However, clumps were small enough to pass through the nipple and be consumed by calves.
Calves scoured (fecal score ≥2 ) for a mean of 17.8 d (SE = 0.5) or approximately 68% of the experiment. However, most scours were minor (fecal score = 2 ) during the study and were probably related to the feeding program (no calf starter or hay offered).
Body weight at 26 d and BW gain were improved by inclusion of GL or tended ( P < 0.10) to be improved by inclusion of antibiotics in the MR. Mean BW gains were 42 and 58% greater when calves were fed MRAB and MRGL, respectively (Table 2) . Mean BW gain for the 26-d period was 166 g/d (SE = 12), which reflected the limited MR consumption in this study. Efficiency of feed utilization for BW gain tended ( P < 0.10) to be improved when antibiotics or GL was fed (Table 2) . Improved efficiency of feed utilization was consistent with reduced incidence of scours and improved BW gain when the consumption of MR is limited. Antibiotics in MR have been shown to reduce the incidence of scours and to improve BW gain in calves (13, 24) . Our study confirms those findings. Results from the use of probiotics (bacterial cultures, oligosaccharides, and yeast) in MR generally have been equivocal. Responses to the addition of these products to MR or calf starter generally have been significant when calves were exposed to stresses (1, 3, 22, 23) and not significant when calves were not stressed (8, 14) . Abe et al. ( 1 ) reported that the addition of bifidobacteria to the diets of calves increased BW gain and reduced fecal scores, particularly when antibiotics were not fed to calves prior to weaning. In the current study, limited MR and a lack of calf starter restricted BW gain and reduced variability of BW gain and feed efficiency. Thus, reduction in the number of days scouring and fecal score were more completely reflected in changes in BW and feed efficiency. Further research is required to determine whether GL influences health, changes in BW, and feed efficiency when calves are fed calf starter for ad libitum consumption and when amounts of MR are more typical of those used in the industry.
CONCLUSIONS
The MRGL and MRAB reduced the severity of scours and increased BW gain and efficiency of feed utilization in this study. Changes in growth and feed efficiency appeared to be related to improvements in intestinal health and reduction of severity and duration of scours. Further research is required to determine whether GL is effective under typical management conditions, including greater MR consumption and ad libitum access to calf starter.
